BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33914691)

  • 1. Using Topical Citric Acid to Treat an Infected Ulcerated Hemangioma in an Infant: A Case Study.
    Nagoba B; Davane M; Warad B; Jamadar N; Gavkare AM
    Wounds; 2021 Feb; 33(2):E17-E19. PubMed ID: 33914691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol.
    Chang CS; Kang GC
    Plast Reconstr Surg Glob Open; 2016 Feb; 4(2):e621. PubMed ID: 27014550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
    Almebayadh M
    J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective Beta-Blockers for the Efficacious Healing of Ulcerated Infantile Hemangiomas in Unusual Locations of Two Female Infants.
    Poulose D; Lote S; Mahajan A; Gogineni JM
    Cureus; 2021 Jul; 13(7):e16683. PubMed ID: 34462702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
    Lie E; Püttgen KB
    Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of ulcers on a segmental hemangioma: A combination of systemic and topical therapies in two pediatric cases].
    Tirelli LL; Luna PC; Panizzardi AA; Larralde M
    Arch Argent Pediatr; 2022 Oct; 120(5):e226-e230. PubMed ID: 36190226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of ulcerated hemangiomas.
    McCuaig CC; Cohen L; Powell J; Hatami A; Marcoux D; Maari C; Caouette-Laberge L; Bortoluzzi P; Ondrejchak S; Dubois J
    J Cutan Med Surg; 2013; 17(4):233-42. PubMed ID: 23815955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor.
    Metz BJ; Rubenstein MC; Levy ML; Metry DW
    Arch Dermatol; 2004 Jul; 140(7):867-70. PubMed ID: 15262700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol versus steroids for the treatment of ulcerated infantile hemangiomas.
    Polites SF; Rodrigue BB; Chute C; Hammill A; Dasgupta R
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27280. PubMed ID: 29932302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
    Chan H; McKay C; Adams S; Wargon O
    Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile hemangiomas, complications and treatments.
    Cheng CE; Friedlander SF
    Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.